期刊文献+

美满霉素抑制GFAP与β-淀粉样蛋白在糖尿病大鼠海马CA3区的表达 被引量:1

Minocycline inhibits expressions of GFAP and β-amyloid protein in diabetic rats'hippocampus CA3 area
原文传递
导出
摘要 目的检测美满霉素对糖尿病大鼠海马CA3区胶质纤维酸性蛋白(GFAP)、β-淀粉样蛋白(Aβ)和炎症因子IL-1β、TNF-α表达的影响,探讨糖尿病糖代谢异常在阿尔采末病中的作用。方法42只Wistar大鼠随机分为对照组(C组)、4 wk模型组(M4组)、6 wk模型组(M6组)、8 wk模型组(M8组)、治疗4 wk组(MT4组)、治疗6 wk组(MT6组)和治疗8 wk组(MT8组),每组6只。腹腔注射链佐星(STZ)诱发糖尿病大鼠动物模型。造模成功后,治疗组给予美满霉素50 mg·kg^(-1)·d^(-1)灌胃,模型组予等量生理盐水灌胃代替。分别选取造模wk 4、6、8作为观察点,行穿梭箱实验、Morris水迷宫实验检测大鼠认知行为学改变,蛋白质免疫印迹法、免疫组织化学法和酶联免疫吸附实验(ELJSA)检测GFAP、Aβ、IL-1β和TNF-α的表达。结果模型组GFAP、Aβ、IL-1β和TNF-α的表达与对照组相比明显增高(P<0.01)。美满霉素治疗后,大鼠认知功能障碍明显改善,GFAP、Aβ、IL-1β和TNF-α表达显著下调(P<0.01)。结论美满霉素可抑制糖尿病大鼠星形胶质细胞激活脑内炎症、抑制Aβ表达,具有脑保护作用。 AIM To investigate the expressions of glial fibrillary acidic protein (GFAP), amyloid betaprotein (Aβ) , IL-1β, and TNF-α in hippocampus CA3 area of diabetes mellitus Wistar rats treated with minocycline, and to study the pathophysiological mechanism of glucose metabolic disorder in Alzheimer' s disease (AD). METHODS Animal models of diabetes mellitus were established by streptozocin (STZ) with intraperitoneal injection. Forty-two Wistar rats were randomly divided into control group (group C) , 4 week diabetes model group (group M4), 6 week diabetes model group (group M6), 8 week diabetes model group (group M8), minocycline treatment 4 week group (group MT4), minocycline treatment 6 week group (group MT6) and minocycline treatment 8 week group (group MT8) with 6 rats for each group. Minocycline treatment groups were treated with minocycline 50 mg ·kg^-1 ·d^-1 intragastric infusion when models were identified to be successful; while diabetes model groups were treated with intragastrie infusion of equal volume of saline. Choosing the point of the week 4, 6 and 8 after models were made as the observing time. Cogn tested with Morris water maze and shuttle box task. Expressions of GFAP, Aβ, IL-1β itive behavior was and TNF-α were measured by Western blotting, immunohistochemistry and enzyme linked immunosorbent assay (ELISA). The absorbance value was measured by imaging analysis. RESULTS Expressions of GFAP, Aβ, IL-1β and TNF-α in MT groups were higher than those of in C and M group (P 〈 0.01 ). After minocycline treated, MT groups showed obvious cognitive improvement with conspicuous down regulation of GFAP, Aβ, IL-1β and TNF-α expressions (P 〈 0.01 ). CONCLUSION Minocycline can inhibit the activated intracranial inflammation of the astroglial cells of the diabetic rats and also the Aβ expression. Minocycline can provide cerebral protection.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2009年第2期97-101,共5页 Chinese Journal of New Drugs and Clinical Remedies
基金 民政部老年学研究项目[民人教科字(2007)-18-3-05]
关键词 糖尿病 美满霉素 神经胶质原纤维酸性蛋白质 炎症 淀粉样Β蛋白 diabetes mellitus minocycline glial fibrillary acidic protein inflammation amyloid betaprotein
  • 相关文献

参考文献11

  • 1VANHANEN M, KOIVISTO K, MOILANEN L, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study[J]. Neurology, 2006, 67(5): 843-847.
  • 2MARTINS IJ, HONE E, FOSTER JK, et al Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease[J]. Mol Psychiatry, 2006, 11 (8) : 721-736.
  • 3涂荣波,董军.β-淀粉样蛋白在老年痴呆症发生发展中的作用及其机制[J].第四军医大学学报,2007,28(1):91-93. 被引量:32
  • 4褚文政,钱采韻.侧脑室注射链脲霉素引起大鼠脑Aβ_(1-40)和Aβ_(1-42)表达增加[J].第四军医大学学报,2005,26(15):1356-1358. 被引量:6
  • 5ELEWA HF, HILAL1 H, HESS DC, et al. Minocycline for short-term neuroprotection[J]. Pharmacotherapy, 2006, 26(4): 515-521.
  • 6CHO KO, LA HO, CHO YJ, et al. Minoeycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion[J]. J Neurosci Res, 2006, 83(2): 285-291.
  • 7冯波,王华,赵秀丽.普伐他汀对糖尿病大鼠动脉组织基因谱表达的影响[J].中国新药与临床杂志,2007,26(3):167-171. 被引量:4
  • 8STIRLING DP, KHODARAHMI K, LIU J, etal. Minacycline treatment reduces delayed oligodendroeyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury[J]. J Neurosci, 2004, 24(9) : 2182-2190.
  • 9YRJANHEIKKI J, KEINANEN R, PELLIKKA M, et al. Tetracyclines inhibit microglial activation and are neuroprotective ill global brain ischemia[J]. Proc Natl Acad Sci U S A, 1998, 95 (26) : 15769-15774.
  • 10LIN S, ZHANG Y, DODEL R, et al. Minocycline blocks nitric oxide-induced neurotoxieity by inhibition p38 MAP kinase in rat eerebellar granule neurons[J]. Neurosci Lett, 2001, 315 ( 1-2 ) : 61-64.

二级参考文献34

  • 1袁敏,房溶娟,裘宇芳.不同剂量辛伐他汀对颈动脉粥样斑块的临床干预[J].中国新药与临床杂志,2005,24(6):447-450. 被引量:2
  • 2冯波,王华,赵秀丽.应用基因芯片探讨阿托伐他汀对糖尿病大鼠动脉组织基因谱表达的影响[J].中华糖尿病杂志(1006-6187),2005,13(6):465-466. 被引量:5
  • 3Sharma M, Gupta YK. Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment[J]. Life Sci, 2001 ; 68(9) : 1021 - 1029.
  • 4Baskin DS, Browning JL, Pirozzolo FJ, et al. Brain choline acetyltransferase and mental function in Alzheimer disease[J]. Arch Neurol, 1999; 56:1221 -1223.
  • 5Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis[ J ]. J Neural Transm, 1998; 105(4-5) : 415 -422.
  • 6Zhao W, Chen H, Xu H, et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats[J]. J Biol Chem, 1999; 274(49) : 34893 -34902.
  • 7Gouras GK, Tsai J, Naslund J, et al. Intraneuronal Abeta42 accumulation in human brain [J]. Am J Pathol, 2000; 156 ( 1 ):15 - 20.
  • 8Mochizuki A, Tamaoka A, Shimohata A, et al. Aβ42-positive nonpyramidal neurons around amyloid plaques in Alzheimer's diease[J]. Lancet, 2000; 355:42-43.
  • 9Hartmann T. IntraceUular biology of Alzheimer's disease amyloid beta peptide[J]. Eur Arch Psychiatry Clin Neurosci, 1999; 249(6):291 - 298.
  • 10包新民 舒斯云.大鼠脑立体定向图谱[M].北京:人民卫生出版社,1991.48-60.

共引文献39

同被引文献42

  • 1Lefebvre P. Diabetes yesterday,today and tomorrow. The action of the International Diabetes Federation [ J ]. Rev Med Liege, 2005,60 ( 5/ 6 ) :273 - 277.
  • 2Mijnhout GS, Scheltens P, Diamant M, et al. Diabetic encephalopa- thy :A concept in need of a definition [ J ]. Diabetologia, 2006,49 (6) :1447 - 1448.
  • 3Mijnhout GS,Schehens P, Diamant M, et al. Diabetic encephalopa- thy: a concept in need of a definition [ J ]. Diabetologia, 2006,49 (6) :1447 - 1448.
  • 4Vijayakumar TM, Sirisha GBN, Farzana Begam MD, et al. Mechanism Linking Cognitive Impairment and Diabetes mellitus [ J ]. European Journal of Applied Sciences ,2012,4( 1 ) : 1 - 5.
  • 5Strachan MWJ. The brain as a target organ in Type 2 diabetes: explo- ring the links with cognitive impairment and dementia[ J ]. Diabet Med,2011,28(2) :141 - 147.
  • 6Christopher T, Kodl MD, Elizabeth R, et al. Cognitive dysfunction and diabetes mellitus [ J ]. Endocr Rev,2008,29 (4) :494 - 511.
  • 7Yaffe K, Falvey CM, Hamilton N, et al. Association between hypogly- cemia and dementia in a biracial cohort of older adults with diabetes mellitus[ J]. JAMA Intern Med ,2013,173 ( 14 ) : 1300 - 1306.
  • 8Ryan CM, Freed MI, Rood JA, et al. Improving metabolic control leads to better working memory in adults with type 2 diabetes[ J]. Di- abetes Care,2006,29(2) :345 -351.
  • 9Punthakee Z, Miller ME, Launer LJ,et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes post hoc epidemiologic analysis of the ACCORD trial[ J]. Diabetes Care,2012,35 (4) :787 - 793.
  • 10Schrijvers EM, Witteman JC, Sijbrands EJ, et al. Insulin metabolism and the risk of Alzheimer disease:the Rotterdam Study [ J ]. Neurolo- gy,2010,75 (22) : 1982 - 1987.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部